What is the point of biosimilars and the promise of lower prices if the only beneficiary is the government's economic interest? Oh wait. The government's economic interest is the only consideration in Australia's HTA system. …
A good idea that will need to overcome an institutional mindset
February 19, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
AstraZeneca maintains its lead as other teams start to build
February 21, 2025 - - Latest News -
PSA members endorse acquisition of the Australasian College of Pharmacy
February 21, 2025 - - Latest News -
First and only treatment for chronic hypoparathyroidism approved in Australia
February 21, 2025 - - Latest News -
Significant gift new Academy for Health Leadership at University of Melbourne
February 21, 2025 - - Latest News -
A good idea that will need to overcome an institutional mindset
February 19, 2025 - - Latest News -
Pharmaceuticals the latest Trump target for tariffs
February 19, 2025 - - Latest News -
IDT delivers strong first-half performance following strategic pivot
February 19, 2025 - - Latest News